Long-term followup needed to define role of infliximab in treatment of renal amyloidosis: Comment on the case report by Elkayam et al [4]

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Access to Document

@article{964965bc62ad45aeb07d8097c7656517,

title = "Long-term followup needed to define role of infliximab in treatment of renal amyloidosis: Comment on the case report by Elkayam et al [4]",

author = "Nurit Tweezer-Zaks and Pnina Langevitz and Avi Livneh",

year = "2003",

month = nov,

doi = "10.1002/art.11316",

language = "אנגלית",

volume = "48",

pages = "3298--3299",

journal = "Arthritis and Rheumatism",

issn = "0004-3591",

publisher = "John Wiley and Sons Ltd",

number = "11",

}

TY - JOUR

T1 - Long-term followup needed to define role of infliximab in treatment of renal amyloidosis

T2 - Comment on the case report by Elkayam et al [4]

AU - Tweezer-Zaks, Nurit

AU - Langevitz, Pnina

AU - Livneh, Avi

PY - 2003/11

Y1 - 2003/11

UR - http://www.scopus.com/inward/record.url?scp=0242411736&partnerID=8YFLogxK

U2 - 10.1002/art.11316

DO - 10.1002/art.11316

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

AN - SCOPUS:0242411736

SN - 0004-3591

VL - 48

SP - 3298

EP - 3299

JO - Arthritis and Rheumatism

JF - Arthritis and Rheumatism

IS - 11

ER -